CLOSEOUT LETTER
McNEIL-PPC, Inc.
- Recipient:
- McNEIL-PPC, Inc.
United States
- Issuing Office:
United States
| |
| Food and Drug Administration New Jersey District Office Central Region Waterview Corporate Center 10 Waterview Blvd. 3rd Floor Parsippany, New Jersey 07054 Telephone: (973) 331-4900 FAX: (973) 331-4969 |
Department of Health and Human Services
May 22, 2014
UNITED PARCEL SERVICE
Lesley Traver
Vice President, Quality and Compliance
McNEIL-PPC, Inc.
199 Grandview Road
Skillman, New Jersey 08558-1311
Dear Ms. Traver:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter (12-NWJ-17), issued on May 22, 2012. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
The letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Capt. Joseph F. McGinnis
Director Compliance Branch
New Jersey District